Cargando…

Improved risk stratification by PET-based intratumor heterogeneity in children with high-risk neuroblastoma

PURPOSE: The substratification of high-risk neuroblastoma is challenging, and new predictive imaging biomarkers are warranted for better patient selection. The aim of the study was to evaluate the prognostic role of PET-based intratumor heterogeneity and its potential ability to improve risk stratif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Chao, Wang, Shaoyan, Li, Can, Yin, Yafu, Feng, Fang, Fu, Hongliang, Wang, Hui, Chen, Suyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637983/ https://www.ncbi.nlm.nih.gov/pubmed/36353561 http://dx.doi.org/10.3389/fonc.2022.896593

Ejemplares similares

Measuring Intratumoral Heterogeneity of Immune Repertoires
por: Yuzhakova, Diana Vladimirovna, et al.
Publicado: (2020)

Intratumor Heterogeneity in Early Lung Adenocarcinoma
por: Senosain, Maria-Fernanda, et al.
Publicado: (2020)

Revealing the intratumoral heterogeneity of non-DS acute megakaryoblastic leukemia in single-cell resolution
por: Su, Narun, et al.
Publicado: (2022)

Intratumor Heterogeneity of MIF Expression Correlates With Extramedullary Involvement of Multiple Myeloma
por: Xu, Juan, et al.
Publicado: (2021)

The Clinical Accuracy and Risk Stratification in End of Therapy (18)F-FDG PET/CT in Burkitt Lymphoma
por: Mo, Yi Wen, et al.
Publicado: (2021)

Effect of the categorization method on the diagnostic performance of ultrasound risk stratification systems for thyroid nodules
por: Fu, Chao, et al.
Publicado: (2023)

Predictive value of intratumoral-metabolic heterogeneity derived from (18)F-FDG PET/CT in distinguishing microsatellite instability status of colorectal carcinoma
por: Zhang, Li, et al.
Publicado: (2023)

(18)F-PSMA-1007 PET/CT Performance on Risk Stratification Discrimination and Distant Metastases Prediction in Newly Diagnosed Prostate Cancer
por: Wang, Zhuonan, et al.
Publicado: (2021)

Editorial: Prognosis prediction and risk stratification in head and neck cancer
por: Li, Tengxiang, et al.
Publicado: (2022)

(18)F-PSMA-1007 PET/CT-derived semi-quantitative parameters for risk stratification of newly diagnosed prostate cancer
por: Dong, Siying, et al.
Publicado: (2022)

Prediction value of (18)F-FDG PET/CT intratumor metabolic heterogeneity parameters for recurrence after radical surgery of stage II/III colorectal cancer
por: Liu, Xin, et al.
Publicado: (2022)

Evaluation of a radiomics nomogram derived from Fluoride-18 PSMA-1007 PET/CT for risk stratification in newly diagnosed prostate cancer
por: Wang, Zhuonan, et al.
Publicado: (2022)

Intratumoral Heterogeneity, Its Contribution to Therapy Resistance and Methodological Caveats to Assessment
por: Renovanz, Mirjam, et al.
Publicado: (2014)

Methylation-based reclassification and risk stratification of skull-base chordomas
por: Huo, Xulei, et al.
Publicado: (2022)

Usefulness of brain FDG PET/CT imaging in pediatric patients with suspected autoimmune encephalitis from a prospective study
por: Yin, Yafu, et al.
Publicado: (2021)

Influence of Intratumor Heterogeneity on the Predictivity of MGMT Gene Promoter Methylation Status in Glioblastoma
por: Brigliadori, Giovanni, et al.
Publicado: (2020)

The Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer—The Impact in Intratumoral Heterogeneity
por: Bettoni, Fabiana, et al.
Publicado: (2019)

Intratumor Heterogeneity Correlates With Reduced Immune Activity and Worse Survival in Melanoma Patients
por: Lin, Zhen, et al.
Publicado: (2020)

Intratumor Heterogeneity as a Prognostic Factor in Solid Tumors: A Systematic Review and Meta-Analysis
por: Yu, Tao, et al.
Publicado: (2021)

Editorial: Risk-stratification in myelodysplastic syndromes
por: Breccia, Massimo, et al.
Publicado: (2022)

Single-Nucleotide Polymorphism Array Technique Generating Valuable Risk-Stratification Information for Patients With Myelodysplastic Syndromes
por: Xiao, Xia, et al.
Publicado: (2020)

The Intratumoral Heterogeneity Reflects the Intertumoral Subtypes of Glioblastoma Multiforme: A Regional Immunohistochemistry Analysis
por: Bergmann, Natalie, et al.
Publicado: (2020)

Risk Stratification in Oral Cancer: A Novel Approach
por: Tu, Irene Wen-Hui, et al.
Publicado: (2022)

Intratumor heterogeneity of driver mutations and TMB distribution in 30 early-stage LUAD patients with multiple lesions
por: Qiu, Yuan, et al.
Publicado: (2022)

Intratumoral microbiome and gastrointestinal cancers
por: Li, Shengnan, et al.
Publicado: (2022)

Evaluation of the Impact of Intratumoral Heterogeneity of Esophageal Cancer on Pathological Diagnosis and P16 Methylation and the Representativity of Endoscopic Biopsy
por: Qin, Yu, et al.
Publicado: (2021)

Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma with MYCN Amplification Plus 11q Deletion
por: Villamón, Eva, et al.
Publicado: (2013)

Prognostic and Risk Stratification Value of Lesion MACC1 Expression in Colorectal Cancer Patients
por: Lin, Aifen, et al.
Publicado: (2019)

The role of PET/CT in radiotherapy for nasopharyngeal carcinoma
por: Li, Hongjia, et al.
Publicado: (2022)

SBRT for the Primary Treatment of Localized Prostate Cancer: The Effect of Gleason Score, Dose and Heterogeneity of Intermediate Risk on Outcome Utilizing 2.2014 NCCN Risk Stratification Guidelines
por: Bernetich, Matthew, et al.
Publicado: (2014)

A Prediction Model Intended for Exploratory Laparoscopy Risk Stratification in Colorectal Cancer Patients With Potential Occult Peritoneal Metastasis
por: Zhang, Yuanxin, et al.
Publicado: (2022)

PTCL, NOS: An update on classification, risk-stratification, and treatment
por: Weiss, Jonathan, et al.
Publicado: (2023)

Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter Analysis
por: Chys, Brecht, et al.
Publicado: (2020)

The Role of Intratumor Heterogeneity in the Response of Metastatic Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors
por: Nicoś, Marcin, et al.
Publicado: (2020)

Comparison of Different Risk-Stratification Systems for the Diagnosis of Benign and Malignant Thyroid Nodules
por: Shen, Yan, et al.
Publicado: (2019)

Targeting the DNA Damage Response for the Treatment of High Risk Neuroblastoma
por: Southgate, Harriet E. D., et al.
Publicado: (2020)

Metabolic reprogramming of cancer-associated fibroblasts in pancreatic cancer contributes to the intratumor heterogeneity of PET-CT
por: Meng, Qingcai, et al.
Publicado: (2023)

PROTAC Bromodomain Inhibitor ARV-825 Displays Anti-Tumor Activity in Neuroblastoma by Repressing Expression of MYCN or c-Myc
por: Li, Zhiheng, et al.
Publicado: (2020)

Reversible Adaptive Plasticity: A Mechanism for Neuroblastoma Cell Heterogeneity and Chemo-Resistance
por: Chakrabarti, Lina, et al.
Publicado: (2012)

Editorial: Identification, risk stratification, and optimized management for Lynch Syndrome
por: Bernstein, Inge, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vjekqdjeb8sq2p198crnv1ihd4